Clik here to view.
Notification That All Shares of Hakushindo Pharmaceutical Have Been Acquired...
TOKYO Shinkowa Pharmaceutical Co., Ltd., (Head Office: Chuo-ku, Tokyo, CEO: Megumi Tanaka) whose goal is to achieve productive aging around the world, has acquired all shares of Hakushindo...
View ArticleClik here to view.
To Accelerate Research on Anti-aging and Age-related Disease,In Light of the...
TOKYO Hakushindo Pharmaceutical Co., Ltd. (head office: Shinjuku-ku, Tokyo, CEO Daizo Shimamura) provided research funding to the Project Research Center For Clinical Trials and Preventative...
View ArticleClik here to view.
Morinaga Milk’s New Probiotic Strain, Bifidobacterium breve A1, May Prevent...
TOKYO Morinaga Milk Industry Co., Ltd. (TOKYO:2264), a leading Japanese dairy product company, today announced the results of a new study investigating the preventive effects of its new probiotic...
View ArticleClik here to view.
药明生物新建商业化生产基地将安装ABEC生产的最大一次性生物反应器
中国无锡、美国宾夕法尼亚州伯利恒市 (美国商业资讯)–全球领先的生物制药技术平台公司药明生物（WuXi Biologics, 2269.HK）今日宣布，将在公司正在筹建的商业化生产基地（药明生物四厂）安装美国知名生产设备供应商ABEC公司4,000升Custom Single Run（CSR®）一次性反应器。在此之前，药明生物已成功测试和评估了ABEC公司的CSR生物反应器技术。...
View ArticleClik here to view.
BIRAC and PerkinElmer Sign Letter of Intent to Promote India-Led Startups and...
NEW DELHI The Biotechnology Industry Research Assistance Council (BIRAC) celebrated its 6th Foundation Day on Tuesday in New Delhi. The event, aptly themed ‘Sustaining Innovation: A Market Driven...
View ArticleClik here to view.
AVITA Medical Announces MIHS Burn Center Press Conference Regarding RECELL®...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX – AVH, OTCQX: AVMXY) announced that Maricopa Integrated Health System (MIHS) Burn Center will hold a press conference today to...
View ArticleClik here to view.
森永乳业的新款益生菌菌株短双歧杆菌A1或可预防阿尔茨海默病发病
东京 (美国商业资讯) — 日本领先的乳制品公司森永乳业株式会社(TOKYO:2264)今天发布了一项研究成果，该研究调查该公司新款益生菌菌株短双歧杆菌A1在一个阿尔茨海默病模型中的预防效应。研究人员发现，短双歧杆菌A1可改善认知缺陷小鼠的空间识别能力以及学习和记忆能力，这表明该菌株对预防人类发生阿尔茨海默病或许有重要作用1。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Co-Diagnostics, Inc. Announces Construction Update at JV Manufacturing...
SALT LAKE CITY Co-Diagnostics, Inc. (NASDAQ: CODX), a diagnostics company with a unique, proprietary platform for the development of molecular diagnostics, announced today an update on the Joint...
View ArticleClik here to view.
Takeda Announces Publication of Final Data from ICLUSIG® (ponatinib) Pivotal...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that final data from the pivotal Phase 2 PACE clinical trial of ICLUSIG (ponatinib) in...
View ArticleClik here to view.
AVITA Medical Announces RECELL® Health Economic Model to be Presented at...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY) announced today that an abstract highlighting an economic model demonstrating the cost benefit of RECELL® in the...
View ArticleClik here to view.
武田宣布发表ICLUSIG® (ponatinib)枢纽性2期PACE血液病试验的终局数据
马萨诸塞州剑桥和日本大阪 (美国商业资讯) — 武田药品工业株式会社(TSE: 4502)今天宣布，《血液》杂志发表ICLUSIG (ponatinib)治疗难治性慢性粒细胞性白血病(CML)或费城染色体阳性急性淋巴细胞性白血病(Ph+...
View ArticleClik here to view.
Seattle Genetics and Astellas Receive FDA Breakthrough Therapy Designation...
BOTHELL, Wash. & TOKYO Seattle Genetics, Inc. (NASDAQ: SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) today announced that the U.S. Food and Drug...
View ArticleClik here to view.
Three Leading Animal Health Companies Join Hands to Launch World-Class...
XI’AN, China Shaanxi Meili Omni-Honesty Animal Health Co., Ltd., China’s world-class vaccine company targeting foot-and-mouth disease in swine, was launched on March 24th with a groundbreaking...
View ArticleClik here to view.
BioWa、LonzaおよびTillotts Pharma AGによるPOTELLIGENT® CHOK1SV™ 技術におけるライセンス契約締結のお知らせ
東京 （ビジネスワイヤ） — 本ニュースリリースは、協和発酵キリン株式会社の米国子会社であるBioWa...
View ArticleClik here to view.
武田薬品がアイクルシグ（ポナチニブ）のピボタル第2相PACE試験から得た最終データのブラッド誌掲載を発表
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） — 武田薬品工業株式会社(TSE: 4502)は本日、難治性の慢性骨髄性白血病（CML）またはフィラデルフィア染色体陽性急性リンパ芽球性白血病（Ph+...
View ArticleClik here to view.
Alnylam Presents New Clinical Results from the APOLLO Phase 3 Study of...
CAMBRIDGE, Mass. Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that the Company presented new results from the APOLLO Phase 3 study of...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Announces Senior Leadership Changes
HYDERABAD, India Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced a change in the makeup of its senior leadership team. Following a 15-year career with the...
View ArticleClik here to view.
JXTGE Announces Sale of Irvine Scientific to FujiFilm
SANTA ANA, Calif. JXTG Nippon Oil & Energy Corporation has announced it has agreed to sell Irvine Scientific Sales Company, Inc. and IS Japan Co., Ltd. to FUJIFILM Corporation (FujiFilm). JXTG...
View ArticleClik here to view.
MaxiNovel Pharmaceuticals, Inc. Announces FDA Orphan Drug Designation for...
GUANGZHOU, China MaxiNovel Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (“FDA”) has granted MaxiNovel Orphan Drug Designation for MAX-40279 in the treatment of...
View ArticleClik here to view.
PHC Holdings Corporation: Announcement of Company Name Change
TOKYO PHC Holdings Corporation (headquarters: Tokyo, Japan) announces its company name change from Panasonic Healthcare Holdings Co., Ltd. to PHC Holdings Corporation, effective April 1, 2018. New...
View Article